In 2021, the heart transplant market value is registered as USD 9,926.86 million and is expected to reach a significant rate of 10.10% with market size of USD 15,813.98 million during the forecast period 2022-2030.
Heart Transplantation is a method that replaces a damaged or diseased heart with a healthy heart from a deceased donor and restores the normal functioning in the human body. It extends the patient’s survival and improves the quality of life. This heart transplant technology is preferred for patients who have the possibility of end-stage heart failure or who have failed for other treatment options. A heart before being implanted can stay alive without the presence of the human body for less than six hours which is stored on ice. TransMedics, Inc introduced the heart transplant device (Heart-in-a box) that is a prototype of functioning hearts surroundings and conditions which overcomes the time constraint of the heart staying alive functioning outside before implantation which augments the heart transplant storage market.
Coronary artery disease is one of the major causes of damage to the heart muscles that lead to heart failure. A few diseases that lead to heart failure are poor exercise tolerance, cough-especially at night, shortness of breath, fatigue, and fluid retention. The International Society for Heart and Lung Transplantation report states that globally, nearly 500-600 pediatric heart transplantation procedures are performed annually which represents around 12% of the total number of heart transplantations performed. The major cause of heart failure in children is a congenital heart defect or cardiomyopathy.
The COVID-19 is a highly contagious disease that is caused by a virus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that is spread from one human to another human. Since 2019, nearly 213 countries are affected by this virus worldwide. The World Health Organization (WHO) declares it as a public health emergency on March 11, 2020. During this pandemic, the demand for medical supplies increases for taking care of the infected people. The atomizers, life support machines, oxygen generators, and monitors are some of the respiratory support devices used in primary clinical treatment.
Due to the lockdowns, the supply chain of the raw material that is required to manufacture the heart transplant devices is disrupted in various countries. The heart transplant companies faced various issues for running the production. This leads to a delay in production. Hence the heart transplant market demand has been declined due to the slowdown of the production of the devices and to maintain the social distance people are staying in their homes and avoiding the treatment. The post-COVID-19, the market demand for heart transplant devices regains.
Increasing the number of patients suffering from cardiovascular disease around the world is rising the demand for the treatment and surgeries related to heart is further surges the heart transplant market price. The rise in the geriatric population and the surging number of patients with high blood cholesterol levels are boosting the future of heart transplants.
Moreover, the growing mortality rate of patients succumbing to heart failure is augmenting the demand for heart transplants globally. The causing factors that affect and develop cardiovascular diseases are changes in lifestyle and food habits which escalate the heart transplant market growth. The surgeries and treatments that use heart transplant devices for carrying out are arrhythmias treatment, coronary artery bypass grafting, aneurysms repair, total artificial hearts or ventricular assist devices, etc., apart from heart transplants which are further projected to accelerate the growth of the heart transplants therapeutics market.
As heart transplantation is a new experiment, this transplant box is not aware of many hospitals, laboratories, cardiac institutes, and research centers. Lack of awareness regarding this technology among the end-users is hindering the market growth. Lack of preservation of organ options in the market and there is no choice to choose for the end-users is limiting the growth of the market. Moreover, the heart transplants treatment price is very high that impeds the market growth.
An increase in demand for quality heart transplant devices is expected to lead to the application of advanced equipment which creates an opportunity to accelerate the growth of the market.
Lack of skilled surgeons for performing the surgeries of a heart transplant and shortage of heart donors are the major challenges projected to limit the market growth in the assessment period.
Study Objectives -
The global heart transplant market has been divided into three segments based on type, end-user, and region.
Based on Type
The heart transplant market types are bifurcated into ventricular assist devices, total artificial hearts, and others.
Based on End-user
The heart transplant market by end-user is classified into hospital, cardiac institute, and others.
Based on Region
Region-wise, the global heart transplant market is categorized into four main geographies like Asia-Pacific, Americas, Europe, and the Middle East & Africa. Out of these regions, the Americas is dominating the largest market share due to the well-developed technology, rising government support for research & development, high healthcare spending, growing patients with coronary artery disease, cardiomyopathy, and heart valve disease.
Regional Analysis -
Geographically, the heart transplant market based on regions is analyzed into four major regions like Asia-Pacific, Europe, America's, and the Middle East & Africa. Among them, due to the various benefits like well-developed technology, rising government support for research & development, high healthcare spending, growing patients with coronary artery disease, cardiomyopathy, and heart valve disease, the Americas is holding the maximum heart transplant market share. Moreover, increasing research & development activities and the concentration of prominent companies are propelling the market growth in this region. The International Society for heart and lung transplantation report states that in 2016, in the U.S, the total number of heart transplants were performed up to the age of 17 years is 444.
Europe holds the second-largest market share due to the government support for research & development and investments required for research. Due to the presence of rapidly developing healthcare technology and high healthcare expenditure, Asia-Pacific is said to be the fastest-growing region. In the emerging countries India and Japan, the treatment costs will be low compared to developed countries which attract global patients in this region. Moreover, the rising demand for quality devices in healthcare is predicted to rise the use of advanced equipment which fuels the growth of the market.
The prominent key players in the heart transplant market outlook are the following:
In May 2019, one of the leading key players, Pfizer, Inc., introduced two new drugs named Vyndaqel and Vyndamax drugs with approval from the Food and Drug Administration (FDA). These drugs can be used for the treatment of hereditary transthyretin-mediated amyloidosis or cardiomyopathy which may lead to heart failure.
In March 2018, the top enterpriser, CareDx, Inc., introduced Heartcare which is a comprehensive diagnostic solution helping in the surveillance of heart patients by combining AlloMap and AlloSure Heart.
This global heart transplant market research includes the Market Overview, COVID-19 analysis, Market Dynamics, Study Objectives, Segment Overview, Regional Analysis, Competitive Landscape, Recent developments, Segmentation Table, and FAQs. The market scenario includes the heart transplant market drivers, restraints, challenges, and opportunities. The heart transplant market forecast segments into three forms as type, end-user, and region.
|Market Size||2030: Significant Value|
|Forecast Units||Value (USD Billion)|
|Report Coverage||Revenue Forecast, Competitive Landscape, Growth Factors, and Trends|
|Segments Covered||Surgery Type and End User|
|Geographies Covered||North America, Europe, Asia-Pacific, and Rest of the World (RoW)|
|Key Vendors||SynCardia Systems, LLC (U.S.), HeartWare International Inc., Apaxis Medical, Inc., Calon Cardio, Optum Inc. (U.S.), Thoratec Corporation (U.S.), CardiacAssist Inc. (U.S.), CARMAT (France)|
|Key Market Opportunities||Increasing demand for quality devices in the healthcare|
|Key Market Drivers||
Heart Transplant market is projected to grow at an 10.10% CAGR between 2022-2030.
The Americas is projected to command the largest share in the Heart Transplant market.
Advancements in drugs and rising prevalence of severe coronary artery disease & heart failure are the key factors driving the Heart Transplant market.
Key players profiled in the Heart Transplant market include Optum Inc., Thoratec Corporation, Calon Cardio, HeartWare, Apaxis Medical, Inc., and SynCardia Systems, LLC.
Extensive R&D activities, strategic alliances, partnerships, acquisitions, and new product launches are the key strategies adopted by industry players to strengthen their position in the Heart Transplant market.